{"data":[{"accessionNo":"0001535264-26-000044","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, $0.0001 Par Value","eventDate":"2026-06-30","reportingPerson":"AWM Investment Company, Inc.","reportingCik":null,"personType":"IA","sharesOwned":146988,"percentOfClass":5.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000947871-26-000803","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":132200,"percentOfClass":4.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000947871-26-000803","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"OrbiMed Capital LLC","reportingCik":null,"personType":"IA","sharesOwned":67800,"percentOfClass":2.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097316","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":67717,"percentOfClass":2.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097316","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":67717,"percentOfClass":2.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":51919,"percentOfClass":1.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":46960,"percentOfClass":1.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":46960,"percentOfClass":1.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":46960,"percentOfClass":1.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":4959,"percentOfClass":0.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":4959,"percentOfClass":0.2,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-097149","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":1684,"percentOfClass":0.1,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-090581","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":160981,"percentOfClass":5.8,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-090581","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":160981,"percentOfClass":5.8,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-090581","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":160981,"percentOfClass":5.8,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-090581","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":160981,"percentOfClass":5.8,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002012383-26-003098","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES INC","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":187836,"percentOfClass":6.8,"filedAt":"2026-07-30","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-034786","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"AIGH Capital Management LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":250000,"percentOfClass":9.1,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-034786","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Orin Hirschman","reportingCik":null,"personType":"HC,IN","sharesOwned":250000,"percentOfClass":9.1,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":70065,"percentOfClass":5.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":69999,"percentOfClass":5.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":69999,"percentOfClass":5.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":69999,"percentOfClass":5.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-002385","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":61670,"percentOfClass":4.49,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-002385","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":61670,"percentOfClass":4.49,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-002385","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":61670,"percentOfClass":4.49,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":48796,"percentOfClass":3.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":48796,"percentOfClass":3.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000156","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":48796,"percentOfClass":3.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000016","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":12200,"percentOfClass":0.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000016","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":12200,"percentOfClass":0.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000016","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":12200,"percentOfClass":0.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000016","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":12200,"percentOfClass":0.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":66,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":66,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-062745","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":66,"percentOfClass":0,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-26-212415","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":121356,"percentOfClass":4.8,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-26-212415","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":121356,"percentOfClass":4.8,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000905148-26-001890","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-22","reportingPerson":"Michael Gelband","reportingCik":null,"personType":"IN,HC","sharesOwned":22000,"percentOfClass":0.8,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000905148-26-001890","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-22","reportingPerson":"ExodusPoint Capital Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":22000,"percentOfClass":0.8,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000905148-26-001890","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":"85209E208","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-22","reportingPerson":"ExodusPoint Capital Partners GP, LLC","reportingCik":null,"personType":"CO,HC","sharesOwned":22000,"percentOfClass":0.8,"filedAt":"2026-04-28","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-019183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":103026,"percentOfClass":9.6,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-019183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":103026,"percentOfClass":9.6,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-019183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":103026,"percentOfClass":9.6,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-019183","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-17","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":102971,"percentOfClass":9.6,"filedAt":"2026-02-24","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Abingworth Bioventures VII LP","reportingCik":"0001688313","personType":"PN","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Abingworth LLP","reportingCik":"0001397144","personType":"PN","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"The Carlyle Group Inc.","reportingCik":"0001527166","personType":"CO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I GP Inc.","reportingCik":"0001548626","personType":"CO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I GP Sub L.L.C.","reportingCik":"0001548627","personType":"OO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Holdings I L.P.","reportingCik":"0001548628","personType":"PN","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"CG Subsidiary Holdings L.L.C.","reportingCik":"0001790577","personType":"OO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"TC Group, L.L.C.","reportingCik":"0000933790","personType":"OO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Investment Management L.L.C.","reportingCik":"0001354120","personType":"OO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001493152-26-007364","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Carlyle Genesis UK LLC","reportingCik":"0001941860","personType":"OO","sharesOwned":50893,"percentOfClass":4.7,"filedAt":"2026-02-18","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":70000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":70000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":70000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":70000,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":70035,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":69999,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":69999,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":69999,"percentOfClass":6.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-001188","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Alyeska Investment Group, L.P.","reportingCik":null,"personType":"IA","sharesOwned":61670,"percentOfClass":5.79,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-001188","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Alyeska Fund GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":61670,"percentOfClass":5.79,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001172661-26-001188","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Anand Parekh","reportingCik":null,"personType":"IN","sharesOwned":61670,"percentOfClass":5.79,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016661","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"ADAR1 Capital Management, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":58000,"percentOfClass":5.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016661","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Daniel Schneeberger","reportingCik":null,"personType":"HC,IN","sharesOwned":58000,"percentOfClass":5.4,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":36,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":36,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-26-016495","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":36,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000039","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":58949,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000039","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":58949,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0000902219-26-000039","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc","ticker":"SPRB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":58949,"percentOfClass":5.5,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002096947-25-000001","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stok, par value $0.0001","eventDate":"2025-11-21","reportingPerson":"Boone Peter David Mr","reportingCik":null,"personType":"IN","sharesOwned":68184,"percentOfClass":6.4,"filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-25-272439","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":121356,"percentOfClass":11.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-25-272439","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":121356,"percentOfClass":11.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel Advisors LLC","reportingCik":null,"personType":"IA,HC,OO","sharesOwned":109649,"percentOfClass":9.99,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel Advisors Holdings LP","reportingCik":null,"personType":"HC,PN","sharesOwned":109649,"percentOfClass":9.99,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":109649,"percentOfClass":9.99,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Kenneth Griffin","reportingCik":null,"personType":"HC,IN","sharesOwned":109649,"percentOfClass":9.99,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel Securities Group LP","reportingCik":null,"personType":"HC,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel Securities LLC","reportingCik":null,"personType":"BD,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001104659-25-100138","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share (the \"Shares\")","eventDate":"2025-10-09","reportingPerson":"Citadel Securities GP LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-08","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":70000,"percentOfClass":6.6,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-08","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":70000,"percentOfClass":6.6,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-08","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":70000,"percentOfClass":6.6,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0002050709-25-000008","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"SPRUCE BIOSCIENCES, INC.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-08","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":62000,"percentOfClass":5.8,"filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001012975-25-000624","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-07","reportingPerson":"HealthCap VIII, L.P.","reportingCik":"0001783281","personType":"PN","sharesOwned":36640,"percentOfClass":3.4,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001012975-25-000624","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001683553","issuerName":"Spruce Biosciences, Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-07","reportingPerson":"HealthCap VIII GP LLC","reportingCik":null,"personType":"PN","sharesOwned":36640,"percentOfClass":3.4,"filedAt":"2025-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-25-234169","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-06","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":121356,"percentOfClass":21.6,"filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"},{"accessionNo":"0001193125-25-234169","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001683553","issuerName":"Spruce Biosciences Inc.","ticker":"SPRB","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-06","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":121356,"percentOfClass":21.6,"filedAt":"2025-10-08","canonicalUrl":"https://xoomar.com/markets/stocks/sprb"}],"updatedAt":"2026-11-05T13:14:00.791Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/sprb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}